Anna Backmark

Also affiliated with AstraZeneca (Italy), AstraZeneca (Sweden), AstraZeneca (Germany)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis”.

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis

Scientific Reports(2021)10.1038/s41598-021-99008-2

N/A

0DataRank · unranked

19 citations

Christine Becker, Benjamin Readhead, Nicolas Goossens, Jacqueline L. Buros, Maria Isabel Fiel +7 more

Repositioning of a Novel GABA-B Receptor Agonist, AZD3355 (Lesogaberan), for the Treatment of Non-alcoholic Steatohepatitis

Research Square(2021)10.21203/rs.3.rs-386482/v1

N/A

0DataRank · unranked

0 citations

Christine Becker, Benjamin Readhead, Nicolas Goossens, Jacqueline L. Buros, Maria Isabel Fiel +7 more

Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202010-3832oc

N/A

0DataRank · unranked

118 citations

Christine Becker, Daniel G. Foster, Maurizio Chioccioli, Meghan Nelson, K.M. Beke +29 more

Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in In Vitro, In Vivo and Ex Vivo Models of Pulmonary Fibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.04.474955

N/A

0DataRank · unranked

1 citations

Christine Becker, Daniel G. Foster, Maurizio Chioccioli, Meghan Nelson, K.M. Beke +24 more